UCP2 and status epilepticus: Rats that received UCP2 antisense oligonucleotide administration presented 100% onset of SE (i.e., all animals treated with ASO followed by pilocarpine administration developed status epilepticus, n = 10). In contrast, animals that received only pilocarpine were less prone to enter status epilepticus (7 from 12 rats).